On 2rd November 2021, Shanghai MicroPort? MedBot (Group) Co., Ltd.(“MedBot", stock code: 02252.HK)  completed its initial public offering of H shares and was successfully listed on the main board of Stock Exchange of Hong Kong Limited. Jia Yuan acted as PRC Legal Advisor and provided professional legal services for its H-share listing and the "full circulation" of H-shares.

Official established  in May 2015, MicroPort MedBot is the first tier surgical robot company in the world. It is committed to designing, developing and commercializing surgical robots to assist surgeons in completing complex surgical operations.  MedBot is the only surgical robot company worldwide with a product portfolio covering the five major and rapidly growing surgical specialties of laparoscopic, orthopedic, panvascular, natural orifice and percutaneous surgical procedures, currently has one approved and eight pipeline products. The Company’s three flagship products — the Toumai? Laparoscopic Surgery Robot (“Toumai?”), the DFVision? 3D Electronic Laparoscope (“DFVision?”), and the Honghu Orthopedic Surgical Robot ("Honghu") — have been admitted to the National Medical Products Administration’s (NMPA) Special Approval Procedure for Innovative Medical Devices (the “Green Path”). In addition, DFVision? was approved for marketing by NMPA in June 2021.

This listing is a spin off of Shanghai MicroPort? Medical (Group) Co., Ltd. (00853.HK),  a listed company of H shares, to list its subsidiary on the main board of the Hong Kong Stock Exchange.  After the completion of the issuance and listing, MedBot will become the first surgical robot company listed on the Hong Kong Stock Exchange.  A total number of 36,200,000 shares were issued in this offering, at the price of HK$43.20 per share, rasing a total of HK$1564 million (USD 201 million). The main purposes of raising the fund are for the product development, commercialization and daily operation.

In July 2019, Jia Yuan assisted MicroPort? Medical spin off its subsidiary Endovastec (Stock Code: 688016. SH) and was listed on the STAR Board of Shanghai Stock Exchange, which becoming the first company to spin off from a listed company and be listed on the STAR Board. The listing of MedBot, a subsidiary of MicroPort? Medical, is another typical case in the field of spin off listing of listed companies and unprofitable enterprises, which has great significance.

In the process of MedBot ’s H-share listing, Jia Yuan adheres to the concept of "diligence, prudence, cooperation and excellence", and provides services for the company's joint-stock restructuring, standardized operation, implementation of equity incentive scheme, application for pn15 of HKex, application for state-owned equity setting, preparation of listing documents, application for "full circulation" of H shares, providing feedback to the CSRC, HKex and other authorities throughout the process.

The legal team of Jia Yuan who provided legal services for this project includes  WANG Yuan (senior partner), FU Yangyuan (senior partner), CHEN Qian, CHEN Yun, WANG Saiqi, SHENG Yeqing.